GENTA INCORPORATED /DE/
4, 1998-10-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4, 1998-10-07
Next: DREYFUS PREMIER INTERNATIONAL GROWTH FUND INC, 485APOS, 1998-10-07



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   The, Aries Trust
   c/o Paramount Capital Asset Management. Inc.
   787 Seventh Avenue, 48th Floor
   New York, NY  10019
   
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   SEPTEMBER / 1998
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock, par value    |9/1/98| P  | |    12,800        | A |  $0.939   |                   |  D   |
$0.01 per share            |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/2/98| P  | |    12,750        | A |  $1.039   |                   |  D   |
                           |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/3/98| P  | |    12,770        | A |  $1.00    |                   |  D   |
                           |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/4/98| P  | |    12,770        | A |  $0.956   |                   |  D   |
                           |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/8/98| P  | |    18,900        | A |  $1.017   |                   |  D   |
                           |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/9/98| P  | |    18,900        | A |  $1.031   |                   |  D   |
                           |      |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/10/9| P  | |    18,900        | A |  $0.957   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/11/9| P  | |    18,900        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/14/9| P  | |    21,100        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/15/9| P  | |    28,500        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/16/9| P  | |    20,000        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
___________________________________________________________________________________________________________________________________|

                                                                     Page 1 of 3

<PAGE>

- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/17/9| P  | |    21,100        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/18/9| P  | |    21,100        | A |  $0.991   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/21/9| P  | |    23,900        | A |  $1.00    |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/22/9| P  | |    24,000        | A |  $1.00    |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/23/9| P  | |    23,900        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/24/9| P  | |    24,000        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/25/9| P  | |    23,900        | A |  $0.969   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/28/9| P  | |    32,000        | A |  $0.938   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/29/9| P  | |    32,000        | A |  $0.938   |                   |  D   |
                           |8     |    | |                  |   |           |                   |      |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |9/30/9| P  | |    24,300        | A |  $0.969   |10,577,063         |  D   |
                           |8     |    | |                  |   |           |                   |      |
___________________________________________________________________________________________________________________________________|


<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:

See Attachment A

SIGNATURE  OF  REPORTING  PERSON  
/s/Lindsay  A.  Rosenwald,  M.D.
- --------------------------------------------
Lindsay  A.  Rosenwald,  M.D.,  President
Paramount  Capital Asset  Management,  Inc.,
Investment  Manager The Aries Trust 
DATE 
10/07/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.
 
Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.

Page 2 of 3

<PAGE>

                                  Attachment A


                  Reporting Person:         The Aries Trust
                  Issuer:                   Genta Incorporated (GNTA)
                  Statement For:            September 1998

         Paramount Capital Asset Management, Inc. ("Paramount"),  the Investment
Manager to The Aries Trust (the  "Trust"),  is also the  General  Partner of the
Aries Domestic Fund (the  "Partnership" and, together with the Trust, the "Aries
Funds"),  a Delaware  limited  partnership,  which also owns  securities  of the
Issuer.  Lindsay A.  Rosenwald,  M.D.,  is the sole  shareholder  of  Paramount.
Paramount and Dr. Rosenwald disclaim beneficial ownership of the securities held
by the  Partnership  and the  Trust,  except to the  extent  of their  pecuniary
interest therein. Pursuant to certain agreements, the Aries Funds have the right
to  designate  a majority  of the  Issuer's  Board of  Directors,  however,  the
Reporting Person disclaims status as a Director of the Issuer.

                                                                     Page 3 of 3



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission